Healthtech Startups

Imaginab develops advanced imaging solutions for immuno-oncology that visualize immune cell activity and treatment response without invasive biopsies. The company serves oncologists and clinical researchers seeking non-invasive alternatives for patient monitoring and treatment decision-making.

2 investors

Imagine Pediatrics develops personalized, integrated care models for children with special health care needs, focusing on improving patient outcomes through value-based care approaches.

2 investors

2 investors

Immersive Labz builds immersive medical education solutions, including Cadaviz, a virtual human dissection platform that enables learners to visualize and study detailed 3D anatomical models for gross anatomy, radiology, histology, and clinical applications. The company serves medical institutions, educators, and healthcare learners globally seeking to modernize anatomy and clinical education.

2 investors

Immuneel Therapeutics develops and manufactures cell-based immunotherapies, including CAR-T therapies, for cancer patients, with in-house cGMP lentiviral vector manufacturing. The company aims to make next-generation cell therapies affordable and accessible in India, with a global outlook.

2 investors

Immuneoncia develops immuno-oncology cancer therapeutics, including antibody drugs targeting PD-L1 and CD47, with a program targeting both CD47 and PD-L1 simultaneously. Based in South Korea, the company works to advance immune-based cancer treatments.

2 investors

IMMUNETHEP is a biotechnology company, spun off from the University of Porto, developing immunology-based technology originating from the Laboratory of Immunology of ICBAS. It conducts R&D from its facilities at Biocant Park in Cantanhede, Portugal.

2 investors

A nonprofit organization that uses machine learning to accelerate vaccine development. The project applies AI techniques to immunology research and vaccine design.

2 investors

ImmunoBiome develops microbiome-based therapeutics targeting intractable immune diseases such as cancer and autoimmune disorders, drawing on immunology, bioinformatics, and microbiome research. The company operates in the biotech and drug development space.

2 investors

Impactica builds API-first infrastructure and a platform that helps organizations improve access to public benefits such as healthcare, food, and housing by automating the enrollment process. It serves managed care organizations, public and nonprofit benefits enrollment agencies, and financial services organizations in the US.

2 investors

Implican is developing a patented anastomotic device that uses two compression rings to fixate bowel walls during colorectal surgery, aiming to achieve primary wound healing and reduce anastomotic leakage. The device targets surgeons treating colorectal cancer patients as an alternative to circular staplers, and is in preclinical/clinical testing.

2 investors

Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics. The company operates in the cardiovascular medical device industry.

2 investors

ImYoo develops a platform that enables continuous, scalable biological data collection from patients outside traditional clinical settings to support precision medicine research and drug development. The platform addresses data gaps in healthcare by gathering longitudinal biological measurements from diverse patient populations to improve diagnostics, treatment matching, and clinical trial outcomes.

2 investors

In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience. The company serves pet owners and veterinarians in the animal health market.

2 investors

Inaedis develops RTAD (Room Temperature Ambient Drying), a biopharmaceutical formulation platform that enables alternative drug delivery routes for monoclonal antibodies and biologics, including subcutaneous, inhaled, and intranasal administration. The platform reduces manufacturing risk and cost for pharmaceutical companies while improving patient access through room-temperature stability and simplified administration.

2 investors

Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.

2 investors

Inception Fertility operates a network of fertility brands spanning the fertility life cycle in North America, including fertility centers, donor egg and sperm banks, treatment financing, tissue storage, a virtual pharmacy, and supplements. It serves fertility patients and intended parents, focusing on patient experience and technology-supported care.

2 investors

Incepto provides a curated platform of AI tools integrated into radiology workflows for European healthcare institutions. The company guides radiologists and hospitals through AI solution selection, integration, and optimization to improve diagnostic accuracy and operational efficiency.

2 investors

Konovo (bringing together InCrowd, Survey Healthcare Global, and GlocalMind) operates an AI- and tech-enabled platform that connects life science researchers and data scientists to vetted healthcare audiences such as physicians, nurses, patients, pharmacists, and payers. It serves market research agencies, biopharma, and medical technology firms conducting primary healthcare research.

2 investors

InCurA develops medical devices focused on bleeding control and hemostatic solutions for surgical, dental, and emergency applications, with manufacturing and distribution across the MENA region and GCC countries. The company uses machine learning-optimized R&D to identify medical needs and commercialize biomedical innovations in markets with access gaps.

2 investors

Incyte is a biopharmaceutical company that develops and commercializes medicines for oncology, hematology, dermatology, and other therapeutic areas. The company focuses on bringing treatments to patients across multiple disease categories.

2 investors

Independa operates Health Hub, a HIPAA-compliant health and wellness platform for seniors that delivers telehealth, video calling, family communication, games, and fitness tools across TVs, tablets, computers, and phones. It serves older adults and their families and caregivers, and works with senior living, home care, PACE, and health organizations.

2 investors

Indomo Tx develops drug delivery technology focused on dermatology and consumer health, aiming to improve patient outcomes by helping individuals manage their own health. It is backed by a team with expertise in drug delivery, dermatology, and clinical and pharmaceutical fields.

2 investors

Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins. The technology, developed at Johns Hopkins University's Laboratory of Precision Immunology, is used for immunology and diagnostics research.

2 investors